A combination of semaglutide and metformin also promotes better glycemic control
Sergey Terushkin, MD, FACS, provides physician oversight for bariatric surgery, obesity treatment, and medical weight loss programs
For patients with established IBD, the gastrointestinal side effects of full-dose GLP-1 therapy can be problematic
Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia
Most plans cover Ozempic when prescribed for diabetes, but it wont be covered for off-label weight loss
That said, if you need the medication for medical reasons such as diabetes, the benefits may outweigh the risks and that decision should always be made with your healthcare provider